https://www.sltrib.com/news/2021/01/12/exclusive-feds-accuse/
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, January 12, 2021
11 hours ago — Buy or sell your Texas Pharmacy with BizQuest, the Original Business for Sale ... Texas Compounding Pharmacy - PRICE REDUCED - MUST SELL Multi state ..
11 hours ago — Buy or sell your Texas Pharmacy with BizQuest, the Original Business for Sale ... Texas Compounding Pharmacy - PRICE REDUCED - MUST SELL Multi state ..
20 hours ago — ... the US Food and Drug Administration's in 2021, according to a new report laying out ... resistance, food safety, and ensuring the quality of compounded drugs.
Utah pharmacy CEO charged with illegally importing...
15 hours ago — In addition to the import being mislabeled, the charges also state that the drugs were "manufactured, prepared, propagated, compounded, and processed in an ...
| 01/12/2021 | 12/21/2020 | Infuscience, Inc. dba Bioscrip Infusion Services | Division of Pharmaceutical Quality Operations I | Compounding Pharmacy/Adulterated Drug Products |
| 01/12/2021 | 11/17/2020 | Bonagens | Division of Human and Animal Food Operations East III | New Drug/Misbranded |
| 01/12/2021 | 12/22/2020 | Speedwinds Nutrition, Inc. | Division of Human and Animal Food Operations West VI | New Drug/Misbranded | ||
| 01/12/2021 | 12/28/2020 | Smarter Nutrition, Inc. | Division of Human and Animal Food Operations West V |
Monday, January 11, 2021
FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia-CA1 works to prevent certain proteins from leaving the nucleus of cancer cells, thereby allowing these proteins to control the growth and prevent the spread of cancerous cells in dogs.
Laverdia-CA1 is the first conditionally approved oral treatment for dogs with lymphoma. Because Laverdia-CA1 is orally administered, owners of dogs with a diagnosis of lymphoma, following a veterinarian prescription and safety directions detailed in a client information sheet, can administer this treatment at home. Laverdia-CA1 is given orally twice per week, with at least 72 hours between doses. Laverdia-CA1 is the second treatment for lymphoma in dogs that the FDA has...https://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-first-oral-tablet-treat-lymphoma-dogs?utm_medium=email&utm_source=govdelivery
Tuesday, January 5, 2021
Wisconsin Pharmacist Accused of Destroying COVID-19 Vaccines Is Allegedly a 'Conspiracy Theorist'
In divorce filings, Steven Brandenburg's wife alleges he was stockpiling bulk food and gunsRead in People: https://apple.news/
Subscribe to:
Posts (Atom)